Wong, Hubert
Razvi, Yasmeen
Hamid, Muhammad Akhter
Mistry, Niraj
Filler, Guido
Article History
Received: 6 February 2023
Accepted: 23 November 2023
First Online: 7 December 2023
Declarations
:
: All methods were carried out in accordance with the Declaration of Helsinki. The present study did not involve experiments on humans and/or the use of human tissue samples. The present analysis involved retrospective data collection from publicly available databases and represented anonymous metadata. As such, formal REB approval was not required.
: Not applicable.
: Dr HW is the founder and CEO of WonderMD Ltd, ON, Canada. Dr GF is a consultant of ProKidney Inc., Raleigh, NC, USA, and has received honoraria of Ultragenyx pharma, Alnylam pharma, and Horizon pharma. No conflicts of interest are present for the remainder of the authors.